Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
Anna Morra(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Sileny Han(KU Leuven), Volker Arndt(German Cancer Research Center), Angela Cox, Fergus J. Couch(Mayo Clinic), Miriam Dwek(University of Cambridge), Peter A. Fasching(Universitätsklinikum Erlangen), Graham G. Giles(The University of Melbourne), Jose E. Castelao(Servicio Gallego de Salud), Simon S. Cross(University of Sheffield), Manuela Gago-Domínguez(University of Southern California), Susan M. Gapstur(Centre international de recherche sur le cancer), Sara Y. Brucker(University Children's Hospital Tübingen), Thilo Dörk(Hannover Re (Germany)), Heiko Becher(Universität Hamburg), Kathleen M. Egan(Moffitt Cancer Center), Päivi Auvinen(University of Eastern Finland), José Á. García-Sáenz(Hospital Clínico San Carlos), Pascal Guénel(Inserm), Alison M. Dunning(University of Cambridge), Kamila Czene(Karolinska Institutet), Thomas U. Ahearn(Harvard University), Douglas F. Easton(University of Cambridge), Sabine Behrens(German Cancer Research Center), Per Hall(Karolinska Institutet), Christine L. Clarke(Memorial University of Newfoundland), Carl Blomqvist(University of Helsinki), Christopher A. Haiman(University of Southern California), Ute Hamann(German Cancer Research Center), Daniele Campa(University of Pisa), Nicola J. Camp(University of Utah), Audrey Jung(German Cancer Research Center), Ji‐Yeob Choi(Seoul National University), Ignacio Briceño(Universidad de La Sabana), Stig E. Bojesen(University of Copenhagen), Renske Keeman(The Netherlands Cancer Institute), Mia M. Gaudet(Cancer Prevention Institute of California), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Mervi Grip(University of Oulu), Laura E. Beane Freeman(National Cancer Institute), D. Gareth Evans(Manchester Academic Health Science Centre), Stephen J. Chanock(National Cancer Institute), Niclas Håkansson(Cancer Prevention Institute of California), Matthias W. Beckmann, Henrik Flyger(Herlev Hospital), Annelie Augustinsson(Lund University), Manjeet K. Bolla(University of Cambridge), Federico Canzian(German Cancer Research Center)
Cited by 40
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k